Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
27.31
+0.18 (0.68%)
Sep 15, 2025, 2:06 PM EDT - Market open
Pacira BioSciences Market Cap
Pacira BioSciences has a market cap or net worth of $1.23 billion as of September 15, 2025. Its market cap has increased by 83.69% in one year.
Market Cap
1.23B
Enterprise Value
1.40B
1-Year Change
83.69%
Ranking
Category
Stock Price
$27.31
Market Cap Chart
Since February 3, 2011, Pacira BioSciences's market cap has increased from $121.00M to $1.23B, an increase of 913.96%. That is a compound annual growth rate of 17.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.22B | 40.09% |
| Dec 31, 2024 | 869.90M | -44.48% |
| Dec 29, 2023 | 1.57B | -11.56% |
| Dec 30, 2022 | 1.77B | -33.90% |
| Dec 31, 2021 | 2.68B | 3.10% |
| Dec 31, 2020 | 2.60B | 37.52% |
| Dec 31, 2019 | 1.89B | 6.88% |
| Dec 31, 2018 | 1.77B | -4.50% |
| Dec 29, 2017 | 1.85B | 53.30% |
| Dec 30, 2016 | 1.21B | -57.20% |
| Dec 31, 2015 | 2.82B | -11.70% |
| Dec 31, 2014 | 3.20B | 65.79% |
| Dec 31, 2013 | 1.93B | 239.05% |
| Dec 31, 2012 | 568.70M | 281.68% |
| Dec 30, 2011 | 149.00M | 23.14% |
| Feb 3, 2011 | 121.00M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |